53: OPTIMISING THE MANAGEMENT OF VANCOMYCIN THERAPY UTILISNG CO-DESIGN

MLA

M. Avent, et al. “53: Optimising the Management of Vancomycin Therapy Utilisng Co-Design.” Journal of Global Antimicrobial Resistance, vol. 31, no. S32-, Nov. 2022. EBSCOhost, https://doi.org/10.1016/S2213-7165(22)00332-0.

APA

M. Avent, W. Franks, K. Daveson, A. Redmond, & S. Naicker. (2022). 53: Optimising the Management of Vancomycin Therapy Utilisng Co-Design. Journal of Global Antimicrobial Resistance, 31(S32-). https://doi.org/10.1016/S2213-7165(22)00332-0

Chicago

M. Avent, W. Franks, K. Daveson, A. Redmond, and S. Naicker. 2022. “53: Optimising the Management of Vancomycin Therapy Utilisng Co-Design.” Journal of Global Antimicrobial Resistance 31 (S32-). doi:10.1016/S2213-7165(22)00332-0.